Monday, 29 April 2024
  
Login

Australia's most trusted
source of pharma news

Monday, 29 April 2024
Ascott/Vivacity
Ascott/Vivacity
Jobs to go in major restructure

This pharma has unveiled a  major restructure to deliver US$1.5 billion in cost savings by the end of 2025 but it will come with the loss of six per cent of the company's global workforce - or 2200 jobs - by the end of this year.

Pharmac wins huge boost in funds
Funding increase coincides with tapping of new Chair
TODAY
Long list of PBAC winners
Positive outcome for most of the new PBS listing submissions
TODAY
Raft of changes to listings ticked
Prescribing changes for one drug benefits a rival
TODAY
JPD
JPD
Salary hikes hit a speed bump
New figures reveal modest increases amid tight budgets
26 April
GM: 'Hardest decision of my life'
Aussie MD to step down after 22yrs at the same company
24 April
AbbVie considered 'the Best' by far
How HCPs in immunology ranked pharma companies
24 April
Who's the TGA taking to court?
NRL team tapes over front-of-jersey sponsor on legal advice
24 April
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (25)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (8)

Other (18)

After 650 days... a PBS listing
Govt subsidy breaks 15-year treatment drought
TODAY
Heart burn drug returns
Company regrows its franchise following TGA suspension
TODAY Approvals Action
CEO pay plummets 87%
Likely the biggest comedown in CEO salaries this year
26 April
Drs don't have time for rep visits
ICYMI: The stories that topped this week
26 April Your Week in Five Minutes
Now that's big: Lilly raises the bar
Revenue from one drug to equal entire sales from 2023
26 April
MA CEO hails vaccine report
Reinforces calls to lower the discount rate for vaccines
26 April
Omico snags new partner
Expanding its reach to Queensland cancer patients
26 April
New life for used blister packs
Surprise transformation for recycled pharma packaging waste
24 April
Boost for potential blockbuster
Combo increases median survival by two-thirds in prostate cancer
24 April
Company looks beyond the ASX
Opportunities with Haleon open up under global growth strategy
24 April
Pharma headhunting gone wrong
Some approaches are driving prospective hires away
23 April
Who's the new AusBiotech CEO?
Well-known company leader takes top industry role
23 April
Why this pharmacy is a 'champion'
Beats a tough field to take out national recognition
23 April
New hope for Roche's PD drug
Post hoc analysis of data shows potential in a subset of patients
23 April
PiF jobs
PiF jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.